Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre

Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre

Abstract In urea cycle disorders (UCDs) ammonia scavenger drugs, usually sodium‐based, have been the mainstay of treatment. Increasingly, glycerol phenylbutyrate (GPB, Ravicti®) is being used but scant real‐world data exist regarding clinical outcomes. A retrospective study of UCD patients initiated...

Full description

Bibliographic Details
Main Authors:	Mildrid Yeo, Preeya Rehsi, Megan Dorman, Stephanie Grunewald, Julien Baruteau, Anupam Chakrapani, Emma Footitt, Helen Prunty, Melanie McSweeney
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Series:	JIMD Reports
Subjects:	glycerol phenylbutyrate hyperammonaemia Ravicti sodium benzoate sodium phenylbutyrate urea cycle disorders
Online Access:	https://doi.org/10.1002/jmd2.12386

Similar Items

Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders
by: Mildrid Yeo, et al.
Published: (2022-03-01)

Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain
by: Elena Martín-Hernández, et al.
Published: (2022-08-01)

Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate
by: Sarah Catharina Grünert, et al.
Published: (2022-11-01)

The burden of pharmacological treatment on health-related quality of life in people with a urea cycle disorder: a qualitative study
by: Gillian Yeowell, et al.
Published: (2021-10-01)

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate
by: M. Mokhtarani, et al.
Published: (2015-12-01)

Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: patient perspectives
by: Peña-Quintana L, et al.
Published: (2017-09-01)

Averting the foul taste of pediatric medicines improves adherence and can be lifesaving – Pheburane® (sodium phenylbutyrate)
by: Koren G, et al.
Published: (2016-10-01)

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
by: Al-Keilani MS, et al.
Published: (2018-10-01)

Suppression of fibrosis in human pterygium fibroblasts by butyrate and phenylbutyrate
by: Yuka Koga, et al.
Published: (2017-09-01)

Pretreatment with Sodium Phenylbutyrate Alleviates Cerebral Ischemia/Reperfusion Injury by Upregulating DJ-1 Protein
by: Rui-Xin Yang, et al.
Published: (2017-06-01)

TLR2/4-mediated NF-κB pathway combined with the histone modification regulates β-defensins and interleukins expression by sodium phenyl butyrate in porcine intestinal epithelial cells
by: Xiujing Dou, et al.
Published: (2018-12-01)

Sodium 4-Phenylbutyrate Protects Hypoxic-Ischemic Brain Injury via Attenuating Endoplasmic Reticulum Stress in Neonatal Rats
by: Ziyi Wu, et al.
Published: (2021-02-01)

Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy?
by: Nitin K. Ahuja, et al.
Published: (2014-03-01)

Sodium Phenylbutyrate Ameliorates Inflammatory Response Induced by <i>Staphylococcus aureus</i> Lipoteichoic Acid via Suppressing TLR2/NF-κB/NLRP3 Pathways in MAC-T Cells
by: Xin Wang, et al.
Published: (2018-11-01)

The effects of the Histone Deacetylase (HDAC) Inhibitor 4-Phenylbutyrate on gap junction conductance and permeability
by: Joshua eKaufman, et al.
Published: (2013-09-01)

Refeeding syndrome in a young woman with argininosuccinate lyase deficiency
by: M. Stuy, et al.
Published: (2015-09-01)

Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands
by: Theresa Mendrina, et al.
Published: (2023-02-01)

Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate
by: Kindness L. Commey, et al.
Published: (2024-01-01)

Major advances in amyotrophic lateral sclerosis in 2020
by: Divyani Garg, et al.
Published: (2021-01-01)

Sodium valproate induced hyperammonaemia in an elderly patient with affective disorder
by: Kumanan Thirunavukarasu, et al.
Published: (2011-06-01)

Andrographolide and 4-Phenylbutyric Acid Administration Increase the Expression of Antimicrobial Peptides Beta-Defensin-1 and Cathelicidin and Reduce Mortality in Murine Sepsis
by: Albert Bolatchiev, et al.
Published: (2022-11-01)

Inhibition of histone deacetylase (HDAC) by 4-phenylbutyrate results in increased junctional conductance between rat corpora smooth muscle cells.
by: Hong Zhan Wang, et al.
Published: (2015-02-01)

Coupling of Bioreaction and Separation via Novel Thermosensitive Ionic Liquids Applied in the Baker’s Yeast-Catalyzed Reduction of Ethyl 2-oxo-4-phenylbutyrate
by: Yuexi Yang, et al.
Published: (2020-04-01)

Study of the Structural Chemistry of the Inclusion Complexation of 4-Phenylbutyrate and Related Compounds with Cyclodextrins in Solution: Differences in Inclusion Mode with Cavity Size Dependency
by: Kindness L. Commey, et al.
Published: (2023-10-01)

The F309S mutation increases factor VIII secretion in human cell line
by: Daianne Maciely Carvalho Fantacini, et al.
Published: (2016-06-01)

A Small Molecule, 4-Phenylbutyric Acid, Suppresses HCV Replication via Epigenetically Induced Hepatic Hepcidin
by: Kiyoon Kim, et al.
Published: (2020-08-01)

Experimental and Bioinformatic Insights into the Effects of Epileptogenic Variants on the Function and Trafficking of the GABA Transporter GAT-1
by: Dolores Piniella, et al.
Published: (2023-01-01)

Multi-parameter Behavioral Phenotyping of the MPP+ Model of Parkinson’s Disease in Zebrafish
by: Christian Christensen, et al.
Published: (2020-12-01)

4‐Phenylbutyric acid, a potent endoplasmic reticulum stress inhibitor, attenuates the severity of collagen‐induced arthritis in mice via inhibition of proliferation and inflammatory responses of synovial fibroblasts
by: Yunjung Choi, et al.
Published: (2021-07-01)

Quantification of the Chemical Chaperone 4-Phenylbutyric Acid (4-PBA) in Cell Culture Media via LC-HRMS: Applications in Fields of Neurodegeneration and Cancer
by: Salvatore Villani, et al.
Published: (2023-02-01)

A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats
by: Soojin Kim, et al.
Published: (2020-09-01)

A Histone Deacetylase Inhibitor Manifests Synergistic Interaction with Artesunate by Suppressing DNA Repair Activity
by: Asif Raza, et al.
Published: (2022-10-01)

Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model
by: Carolina Uggenti, et al.
Published: (2016-11-01)

Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis
by: Rebecca A Chanoux, et al.
Published: (2012-07-01)

The Synthesis of Glycerol Carbonate from Biodiesel By product Glycerol and Urea over Amberlyst 15
by: Reviana Inda Dwi Suyatmo, et al.
Published: (2017-12-01)

Sodium benzoate, food grade
by: 982 SIRIM

Clinical status, biochemical profile and management of a single cohort of patients with arginase deficiency
by: Nandaki Keshavan, et al.
Published: (2022-03-01)

Citrinin-Induced Hepatotoxicity in Mice Is Regulated by the Ca<sup>2+</sup>/Endoplasmic Reticulum Stress Signaling Pathway
by: Dongyi Wu, et al.
Published: (2022-04-01)

Recurrent hyperammonaemia in a patient with carbonic anhydrase VA deficiency
by: Christopher Stockdale, et al.
Published: (2022-11-01)

Reaction Kinetics and Mechanism for the Synthesis of Glycerol Carbonate from Glycerol and Urea Using ZnSO<sub>4</sub> as a Catalyst
by: Huajun Wang, et al.
Published: (2024-01-01)